Cargando…

Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions

Intraperitoneal administration of antibiotics together with peritoneal dialysis fluids (PDFs) remains the preferable route for treatment of peritoneal dialysis-related peritonitis. For home based therapy, antibiotic-containing PDFs are stored for up to two weeks and warmed up to body-temperature bef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kussmann, Manuel, Ferth, Alexander, Obermüller, Markus, Pichler, Petra, Zeitlinger, Markus, Wiesholzer, Martin, Burgmann, Heinz, Poeppl, Wolfgang, Reznicek, Gottfried
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482149/ https://www.ncbi.nlm.nih.gov/pubmed/31019280 http://dx.doi.org/10.1038/s41598-019-42854-y

Ejemplares similares

Compatibility of aztreonam in four commercial peritoneal dialysis fluids
por: Tobudic, Selma, et al.
Publicado: (2020)

Compatibility of fosfomycin with different commercial peritoneal dialysis solutions
por: Kussmann, M., et al.
Publicado: (2017)

Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa
por: Kussmann, Manuel, et al.
Publicado: (2018)

Stability and compatibility of antibiotics in peritoneal dialysis solutions
por: So, Simon Wai Yin, et al.
Publicado: (2022)

Dalbavancin for treatment of implant-related methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model
por: Kussmann, Manuel, et al.
Publicado: (2018)

Culture-directed antibiotics in peritoneal dialysis solutions: a systematic review focused on stability and compatibility
por: Ling, Chau Wei, et al.
Publicado: (2023)

Peritoneal dialysis-related peritonitis: challenges and solutions
por: Salzer, William L
Publicado: (2018)

Pharmacokinetics of the P-gp Inhibitor Tariquidar in Rats After Intravenous, Oral, and Intraperitoneal Administration
por: Matzneller, Peter, et al.
Publicado: (2018)

Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis
por: Kussmann, Manuel, et al.
Publicado: (2018)

Azithromycin concentrations during long-term regimen, a pilot study in patients with MALT lymphoma
por: Scheibenpflug, Raphael, et al.
Publicado: (2021)

Peritoneal Fluid Transport rather than Peritoneal Solute Transport Associates with Dialysis Vintage and Age of Peritoneal Dialysis Patients
por: Waniewski, Jacek, et al.
Publicado: (2016)

Treatment with Oral Active Vitamin D Is Associated with Decreased Risk of Peritonitis and Improved Survival in Patients on Peritoneal Dialysis
por: Kerschbaum, Julia, et al.
Publicado: (2013)

Increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solution
por: Hamasaki, Yoshifumi, et al.
Publicado: (2014)

Challenges and possible solutions to peritoneal dialysis use in Nigeria
por: Ajayi, Samuel, et al.
Publicado: (2020)

Is Assisted Peritoneal Dialysis a Solution for Northern Manitoba?
por: Lavoie, Josée G., et al.
Publicado: (2019)

Glycine improves peritoneal vasoreactivity to dialysis solutions in the elderly
por: Zakaria, El Rasheid, et al.
Publicado: (2019)

Unfavorable Effects of Peritoneal Dialysis Solutions on the Peritoneal Membrane: The Role of Oxidative Stress
por: Roumeliotis, Stefanos, et al.
Publicado: (2020)

Human Borrelia miyamotoi Infection, Austria
por: Tobudic, Selma, et al.
Publicado: (2020)

Survival of Peritoneal Membrane Function on Biocompatible Dialysis Solutions in a Peritoneal Dialysis Cohort Assessed by a Novel Test
por: Balafa, Olga, et al.
Publicado: (2021)

Availability of assisted peritoneal dialysis in Europe: call for increased and equal access
por: Brown, Edwina A, et al.
Publicado: (2022)

The calcium concentration of peritoneal dialysis solution modifies levels of key mediators of peritoneal fibrosis
por: Miao, Chusheng, et al.
Publicado: (2020)

Resolution of severe eosinophilic peritonitis in a patient on continuous ambulatory peritoneal dialysis by changing from Dianeal peritoneal dialysis solution to Stay-Safe Balance solution: a case report
por: Chan, Zi, et al.
Publicado: (2022)

Leishmania (Viannia) guyanensis Infection, Austria
por: Poeppl, Wolfgang, et al.
Publicado: (2012)

The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients
por: Ye, Hongjian, et al.
Publicado: (2017)

Use of Commercially Available Multiplex Polymerase Chain Reaction in Detection of Organism in Culture Negative Peritonitis in Peritoneal Dialysis
por: Veerappan, I., et al.
Publicado: (2019)

Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
por: Alvarez Nadal, Marta, et al.
Publicado: (2020)

Peritoneal Dialysis
por: Pyper, R. A.
Publicado: (1948)

Peritoneal Dialysis
por: Taskapan, Hulya, et al.
Publicado: (2011)

Pooled Analysis on the Effectiveness and Safety of Lipegfilgrastim in Patients With Urological Malignancies in the Real-World Setting
por: Merseburger, Axel S., et al.
Publicado: (2021)

A New Peritoneal Dialysis Solution Containing L-Carnitine and Xylitol for Patients on Continuous Ambulatory Peritoneal Dialysis: First Clinical Experience
por: Rago, Carmela, et al.
Publicado: (2021)

25(OH)D and 1,25(OH)D vitamin D fails to predict sepsis and mortality in a prospective cohort study
por: Ratzinger, Franz, et al.
Publicado: (2017)

Sex Modulates Cardiovascular Effects of Icodextrin-Based Peritoneal Dialysis Solutions
por: Paniagua, Ramón, et al.
Publicado: (2022)

Phosphate Control in Peritoneal Dialysis Patients: Issues, Solutions, and Open Questions
por: Cernaro, Valeria, et al.
Publicado: (2023)

Pharmacodynamics and pharmacokinetics of ciprofloxacin during sustained low-efficiency dialysis
por: Olsen, K, et al.
Publicado: (2014)

Peritoneal Protein Losses and Cytokine Generation in Automated Peritoneal Dialysis with Combined Amino Acids and Glucose Solutions
por: Tjiong, H. L., et al.
Publicado: (2007)

The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients
por: Basturk, Taner, et al.
Publicado: (2012)

Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients
por: Cho, Yeoungjee, et al.
Publicado: (2014)

Gene polymorphisms of VEGF and KDR are associated with initial fast peritoneal solute transfer rate in peritoneal dialysis
por: Qian, Yue, et al.
Publicado: (2022)

Peritoneal Dialysis Complicated by Sclerosing Peritonitis
por: Jiang, Zhifeng, et al.
Publicado: (2022)

Different Types of Coagulase Are Associated With 28-Day Mortality in Patients With Staphylococcus aureus Bloodstream Infections
por: Karer, Matthias, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lo5obu2jb7jk8dep267k3mjsgf